Xiaosong Holdings: Performance Boosted by Increased E-Cigarette Sales

Business by 2FIRSTS.ai
Xiaosong Holdings: Performance Boosted by Increased E-Cigarette Sales
Investors questioned Xiocong Company's acquisition of 30% stake in e-cigarette nicotine company (Shaanxi Ganghua Bio) and its current performance regarding e-cigarette production.

An investor inquired about the current operation status of Guanghua Biochemical, a company in which Xiaosong Corporation acquired a 30% stake through disclosure in Announcement 2022-144. The investor also asked about the annual production volume of nicotine for e-cigarettes by Guanghua Biochemical.


On July 31st, Xiaosong Inc. announced that the operating conditions of Shanxi Ganghua, a company it has invested in, are normal, and the sales of nicotine for e-cigarettes are doing well.


Previously, Xiaosong Co. released its performance forecast for the first half of 2023, revealing a net profit attributable to the company's shareholders ranging from 28 million to 33 million yuan. In the same period last year, the net profit was 3.8986 million yuan, representing a year-on-year increase of 618.21% to 746.46%.


One of the reasons mentioned for the growth in performance is the increase in sales of e-cigarettes.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.